Atlas Trials

Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder

Clinical trial NCT00216723 · COMPLETED

Trial details

NCT number
NCT00216723
Sponsor
Korea Otsuka Pharmaceutical Co., Ltd.
Status
COMPLETED
Study type
OBSERVATIONAL
SchizophreniaBipolar Disorder
Start date
2004-04-01
Enrollment
3000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.